您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Invivo anti-mouse IL-23 (p19) Recombinant mAb

Invivo anti-mouse IL-23 (p19) Recombinant mAb

货号: S0B7004
价格: 900
规格: 1mg
介绍: -
其他: -
产品规格
  • 宿主来源

    Rat
  • 抗原名称

    IL-23 (p19)
  • 分子别名

    Interleukin-23 subunit alpha; IL-23 subunit alpha; IL-23-A; Interleukin-23 subunit p19 (IL-23p19); SGRF; IL23A
  • 细胞定位

    Secreted
  • Accession

    Q9NPF7, P29460
  • 克隆号

    S-2754
  • 抗体类型

    Rat mAb
  • 抗体同种型

    Rat IgG1,k
  • 应用

    Neutralization, WB
  • 反应种属 ?

    Ms
  • 纯化方式

    Protein G
  • 浓度

    5 mg/ml
  • 纯度

    >95% by SDS-PAGE
  • 内毒素含量

    <2EU/mg
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    2 to 8 °C for 2 weeks under sterile conditions;
    -20 °C for 3 months under sterile conditions;
    -80 °C for 24 months under sterile conditions.
    Please avoid repeated freeze-thaw cycles.

稀释度
应用 稀释度 推荐种属
WB 1:1000 Ms
背景介绍
  • Interleukin-23 (IL-23) is a heterodimeric cytokine composed of a p19 subunit and a p40 subunit. The p19 subunit is unique to IL-23, while the p40 subunit is shared with IL-12. IL-23 plays a crucial role in the immune system, particularly in the regulation of T cell responses. It is involved in the differentiation and maintenance of Th17 cells, a subset of T helper cells that produce pro-inflammatory cytokines such as IL-17 and IL-22. These Th17 cells are essential for host defense against extracellular pathogens but can also contribute to chronic inflammation and autoimmune diseases when dysregulated. IL-23 signaling occurs through the IL-23 receptor complex, which includes IL-23R and IL-12Rβ1 subunits, and activates downstream pathways like JAK-STAT, leading to the production of various inflammatory mediators. Due to its involvement in immune-mediated inflammatory diseases, IL-23 has become a target for therapeutic interventions, with several biologics targeting the p19 subunit or the IL-23 receptor being developed and used in the treatment of conditions such as psoriasis, Crohn’s disease, and other autoimmune disorders.

  • 免疫印迹

    • WB result of Invivo anti-mouse IL-23 (p19) Recombinant Rabbit mAb
      Primary antibody: Invivo anti-mouse IL-23 (p19) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: IL-23 Protein, Mouse 1 µg
      Lane 2: IL-23 Protein, Human 1 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 21 kDa
      Observed MW: 17 kDa